Labels

Monday, December 22, 2008

Drotrecogin alfa (activated) treatment in severe s...[Crit Care Med. 2005] - PubMed Result

Drotrecogin alfa (activated) treatment in severe s...[Crit Care Med. 2005] - PubMed Result: "CONCLUSIONS: ENHANCE provides supportive evidence for the favorable benefit/risk ratio observed in PROWESS and suggests that more effective use of drotrecogin alfa (activated) might be obtained by initiating therapy earlier."